Results of CLN fundraise

Summary by AI BETAClose X

Acceler8 Ventures Plc has successfully secured funding commitments of £1,000,000 through the proposed issue of unsecured Convertible Loan Notes, referred to as the 2026 CLNs. These proceeds will be utilized to support the company's near-term working capital requirements. The issuance of these CLNs is contingent upon shareholder approval at a forthcoming general meeting.

Disclaimer*

Acceler8 Ventures PLC
21 April 2026
 

21 April 2026

ACCELER8 VENTURES PLC

Results of CLN fundraise

Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company"), the Main Market listed acquisition company, announces that, further to the announcement made on 8 April 2026 ("CLN Announcement"), AC8 has successfully secured funding commitments of £1,000,000 through the proposed issue of unsecured Convertible Loan Notes ("2026 CLNs").

The 2026 CLNs will be issued to incoming investors, in accordance with the terms set out in the CLN Announcement, with the proceeds from the 2026 CLNs to be used to support the Company's near term working capital requirements, as described in the CLN Announcement.

The issuance of the 2026 CLNs remains conditional on approval by shareholders of the Company of the requisite resolutions at a general meeting of the Company, as set out in the CLN Announcement.

Enquiries:

 




Acceler8 Ventures Plc

David Williams

C/o Tessera Investment Management Limited




Tessera Investment Management Limited

(Financial Adviser to AC8)

Tony Morris
Katie Long
James Strang

Tel: 07742 189145

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings